CompletedNot Applicable

PRIME vs Usual Care for Clinical High Risk

United States16 participantsStarted 2015-01

Plain-language summary

The purpose of this study is to determine whether specialty care is superior to usual care in the treatment of patients at clinical high risk for psychosis.

Who can participate

Age range12 Years – 30 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male or female between 12 and 30 years old.
✓. Understand and sign an informed consent (or assent for minors) document in English.
✓. Meet diagnostic criteria for prodromal syndrome as per COPS criteria.

Exclusion criteria

✕. Diagnosis of current or lifetime Axis I psychotic disorder, including mood disorder with psychotic symptoms.
✕. Impaired intellectual functioning (full-scale IQ\<70). However, those with an IQ in the 65-69 range will not be excluded if they score \>75 on the WRAT Reading.
✕. Past or current history of a clinically significant central nervous system disorder that may contribute to prodromal symptoms or confound their assessment.
✕. Alcohol or substance dependence in the past 6 months.

What they're measuring

Global Assessment of Functioning

Timeframe: 24 months

Trial details

NCT IDNCT02960451

SponsorYale University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-05-01

View on ClinicalTrials.gov More Clinical High Risk Syndrome for Psychosis trials